Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio-Kidney-Metabolic Syndrome.
- DOI
- 10.3390/ijms27208988
- Published
- 2026 Oct 10
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27208988,
title = {Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio-Kidney-Metabolic Syndrome.},
author = {Cortes-Camacho F and Zambrano-Vásquez OR and García-Arroyo FE and Aréchaga-Ocampo E and Castañeda-Sánchez JI and Manzur-Sandoval D and Roldan-Gómez FJ and Valle-Mondragón LD and Aparicio-Trejo OE and Martínez-Olivares CE and Hernández-Pando R and Gonzaga-Sánchez JG and Sánchez-Lozada LG and Osorio-Alonso H},
year = {2026},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms27208988},
url = {https://doi.org/10.3390/ijms27208988}
}RIS
TY - JOUR TI - Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio-Kidney-Metabolic Syndrome. AU - Cortes-Camacho F AU - Zambrano-Vásquez OR AU - García-Arroyo FE AU - Aréchaga-Ocampo E AU - Castañeda-Sánchez JI AU - Manzur-Sandoval D AU - Roldan-Gómez FJ AU - Valle-Mondragón LD AU - Aparicio-Trejo OE AU - Martínez-Olivares CE AU - Hernández-Pando R AU - Gonzaga-Sánchez JG AU - Sánchez-Lozada LG AU - Osorio-Alonso H PY - 2026 JO - International journal of molecular sciences DO - 10.3390/ijms27208988 UR - https://doi.org/10.3390/ijms27208988 ER -
APA
F, C., OR, Z., FE, G., E, A., JI, C., D, M., FJ, R., LD, V., OE, A., CE, M., R, H., JG, G., LG, S., & H, O. (2026). Empagliflozin and Metformin Combination Therapy Attenuates Oxidative Stress and Inflammation in Experimental Cardio-Kidney-Metabolic Syndrome.. International journal of molecular sciences. https://doi.org/10.3390/ijms27208988
Source records
- pubmed · retrieved 2026-11-10T10:03:11.168Z